Walter Kaufmann
Director of Rett Syndrome Program
Boston Children's Hospital
From this contributor
Intellectual disability’s introduction in the DSM-5: What’s the impact?
The move to replace ‘mental retardation’ with ‘intellectual disability’ is widely accepted, but little data exist on the impact of this change.
Intellectual disability’s introduction in the DSM-5: What’s the impact?
Intellectual disability’s DSM-5 debut
The newest edition of the Diagnostic and Statistical Manual of Mental Disorders relies on intellectual function in daily life, both for diagnosing intellectual disability and for determining its level of severity, says Walter Kaufmann.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.